Donald Trump

FDA
Favicon Fierce Pharma

Vinay Prasad is back at the FDA after last month's surprise ouster

“At the FDA’s request,” Vinay Prasad, M.D., is returning to lead CBER, an HHS spokesperson told Fierce Pharma.
Angus Liu Aug 9, 2025 12:22pm
GAO

NIH withholding grant funds is illegal, government watchdog says

Aug 6, 2025 11:15am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Prasad exit signals more permissive FDA for cell and gene field

Jul 31, 2025 9:10am
delay

FDA delays hit clinical trial launch decisions

Jul 30, 2025 10:29am
tariff
Favicon Fierce Pharma

New US-EU trade deal includes 15% tariffs on pharmaceuticals

Jul 29, 2025 10:34am
Pascal Soriot
Favicon Fierce Pharma

AZ reveals plan for huge site in Virginia, part of $50B US outlay

Jul 22, 2025 7:45am